Table 1.
Baseline characteristics of the pathologically-evaluated group and comparison of the pathologically-evaluated normal stomach and others groups
| Characteristics | Total (n = 467) | Pathologically-evaluated normal stomach (n = 96) | Others (n = 371) | P-value | |
|---|---|---|---|---|---|
| Age (years), mean ± SD | 49.7 ± 18.4 (16–88) | 35.1 ± 15.3 | 53.4 ± 17.2 | < 0.05 | |
| Sex (male/female) | 268/199 | 56/40 | 212/159 | 0.83 | |
| PG I (ng/mL) | 43.7 ± 21.5 | 39.5 ± 12.4 | 44.8 ± 23.2 | < 0.05 | |
| PG II (ng/mL) | 14.9 ± 8.64 | 6.67 ± 2.35 | 17.08 ± 8.37 | < 0.05 | |
| PG I/II ratio | 3.57 ± 1.96 | 6.13 ± 1.26 | 2.90 ± 1.50 | < 0.05 | |
| Gastrin (pg/mL) | 159.74 ± 124.41 | 70.9 ± 27.8 | 182.5 ± 146.6 | < 0.05 | |
| Anti-Hp Ab | Positive | 327 | 0 | 327 | < 0.05 |
| Negative | 140 | 96 | 44 | ||
| Endoscopic atrophy (negative/positive) | 120/347 | 96/0 | 24/347 | < 0.05 | |
| Histologic gastritis (Grade 0/1–3)※ | Neutrophil activity | 105/362 | 96/0 | 9/362 | < 0.05 |
| Inflammation | 108/359 | 96/0 | 12/359 | < 0.05 | |
| Atrophy | 153/314 | 96/0 | 57/314 | < 0.05 | |
| Intestinal metaplasia | 355/112 | 96/0 | 259/112 | < 0.05 | |
| Hp infection | 125/342 | 96/0 | 29/342 | < 0.05 | |
※Grade 0–4 (0, none; 1, mild; 2, moderate; 3, severe)
anti-Hp Ab anti-Hp antibody, PG Pepsinogen, Hp Helicobacter pylori, SD Standard deviation